A detailed history of Daiwa Securities Group Inc. transactions in Geron Corp stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 2,247 shares of GERN stock, worth $8,336. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,247
Previous 2,247 -0.0%
Holding current value
$8,336
Previous $10,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$3.1 - $5.09 $2,604 - $4,275
840 Added 59.7%
2,247 $10,000
Q2 2022

Aug 09, 2022

BUY
$1.19 - $1.65 $860 - $1,192
723 Added 105.7%
1,407 $2,000
Q4 2020

Feb 04, 2021

SELL
$1.55 - $2.05 $1,653 - $2,187
-1,067 Reduced 60.94%
684 $1,000
Q3 2020

Nov 02, 2020

BUY
$1.59 - $2.19 $1,384 - $1,907
871 Added 98.98%
1,751 $3,000
Q1 2018

May 02, 2018

BUY
$1.81 - $5.98 $1,592 - $5,262
880 New
880 $4,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.4B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.